Miguel Saro-Buendía

Dr. Miguel Saro-Buendía

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
FLFrancisco Lopez-Medrano
Francisco Lopez-Medrano
MAMaría Asunción Pérez-Jacoiste Asín
María Asunción Pérez-Jacoiste Asín
MFMario Fernández-Ruiz
Mario Fernández-Ruiz
OCOctavio Carretero
Octavio Carretero
ALAntonio Lalueza
Antonio Lalueza
JAJosé María Aguado
José María Aguado
The role of combination immunomodulatory therapy with systemic corticosteroids and tocilizumab (TCZ) for aged patients with COVID-19-associated cytokine release syndrome remains unclear. A retrospective single-center study was conducted on consecutive patients aged ≥65 years who developed severe COVID-19 between 03 March and 01 May 2020 and were treated with corticosteroids at various doses (methylprednisolone 0.5 mg/kg/12 h to 250 mg/24 h), either alone (CS group) or associated with intravenous tocilizumab (400–600 mg, one to three doses) (CS-TCZ group). The primary outcome was all-cause mortality by day +14, whereas secondary outcomes included mortality by day +28 and clinical improvement (discharge and/or a ≥2 point decrease on a 6-point ordinal scale) by day +14. Propensity score (PS)-based adjustment and inverse probability of treatment weights (IPTW) were applied. Totals of 181 and 80 patients were included in the CS and CS-TCZ groups, respectively. All-cause 14-day mortality was lower in the CS-TCZ group, both in the PS-adjusted (hazard ratio [HR]: 0.34; 95% confidence interval [CI]: 0.17–0.68; P = 0.002) and IPTW-weighted models (odds ratio [OR]: 0.38; 95% CI: 0.21–0.68; P = 0.001). This protective effect was also observed for 28-day mortality (PS-adjusted HR: 0.38; 95% CI: 0.21–0.72; P = 0.003). Clinical improvement by day +14 was higher in the CS-TCZ group with IPTW analysis only (OR: 2.26; 95% CI: 1.49–3.41; P < 0.001). The occurrence of secondary infection was similar between both groups. The combination of corticosteroids and TCZ was associated with better outcomes among patients aged ≥65 years with severe COVID-19.

1 January 2023
Verified
Journal Article
Closed access
Miguel Saro-BuendíaMiguel Saro-Buendía
Miguel Saro-Buendía
LTLidia Torres-Garcia
Lidia Torres-Garcia
NANatalia Jaramillo Angel
Natalia Jaramillo Angel
RARaul Mellidez Acosta
Raul Mellidez Acosta
JGJavier Cabrera Guijo
Javier Cabrera Guijo
MCMiguel Armengot Carceller
Miguel Armengot Carceller
Introduction: Dizziness is a common scenario in the Emergency Departments (EDs). Among dizziness un-derlying causes, the posterior circulation stroke is especially relevant due to its mobimortality and concerning misdiagnosis rates. Therefore, we conducted this study to assess dizziness evaluation and baseline characteris-tics of patients with PS in the ED. Methods: We conducted a 3-year retrospective observational study on PS cases confirmed by magnetic resonance imaging (MRI). Concretely, we analysed the demographic profile of these pa-tients, the initial PS clinical presentation, and diagnostic workup (with emphasis on dizziness evaluation) per-formed at the ED. Results: During the study period, 85 cases were registered. Risk factors for cardiovascular disease were present in 85.5% and previous visits to the ED due to dizziness were recorded in 16.5%. The main clinical presentation was dizziness, concretely as an acute vestibular syndrome (38.8%) with additional neuro-logical signs or symptoms (80%). Evaluation by the otolaryngologist on call was requested in less than 10% of the cases and included the HINTS protocol use with a sensitivity of 100% for central nervous system underlying causality. A brain CT study was always performed with a sensitivity of 27%. However, 96.47% of patients were primarily admitted to the Neurology hospitalization ward and MRI was always performed in a mean time of 3.21 days confirming the diagnosis. Conclusion: Dizziness is the most frequent symptom of PS. Patients usually present an AVS (associated with additional N-SS or not) and HINTS bedside examination is the most adequate protocol to differentiate a PS from other AVS causes until the diagnostic confirmation via MRI. Interestingly, mainly otolaryngologists seem to use HINTS. However, the use of CT is widespread despite its poor value.

1 January 2023
Verified
Closed access
Miguel Saro-BuendíaMiguel Saro-Buendía
Miguel Saro-Buendía
PUPedro Suarez Urquiza
Pedro Suarez Urquiza
JGJudit Amigo Gonzalez
Judit Amigo Gonzalez
MNMaria Jose Lesmas Navarro
Maria Jose Lesmas Navarro
MMMiguel Mazon
Miguel Mazon
MCMiguel Armengot Carceller
Miguel Armengot Carceller

2 March 2024 in Indian Journal of Otolaryngology and Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
Miguel Saro-BuendíaMiguel Saro-Buendía
Miguel Saro-Buendía
RPRodolfo David Palacios-Díaz
Rodolfo David Palacios-Díaz
PSPedro Suárez-Urquiza
Pedro Suárez-Urquiza
MMMiguel Mansilla-Polo
Miguel Mansilla-Polo
CBCatalina Bancalari-Díaz
Catalina Bancalari-Díaz
MAMiguel Armengot-Carceller
Miguel Armengot-Carceller
A case of mpox pharyngitis in absence of cutaneous lesions is reported. Usually, clinical presentation is either a cutaneous eruption or a combination of cutaneous and mucosal lesions. In patients with atypical pharyngitis, regardless of the presence of skin lesions, pharyngeal swabs should be collected to rule out mpox.

3 January 2023 in Acta Oto-Laryngologica
Verified
Journal Article
Closed access
Miguel Saro-BuendíaMiguel Saro-Buendía
Miguel Saro-Buendía
LGLidia Torres García
Lidia Torres García
CMClaudia Mossi Martínez
Claudia Mossi Martínez
EAEduardo Battig Arriagada
Eduardo Battig Arriagada
JPJoan Carreres Polo
Joan Carreres Polo
Miguel ArmengotMiguel Armengot
Miguel Armengot
Iodine contrast-induced sialadenitis (CIS) is an uncommon adverse effect to iodine-containing contrast exposition. There is scarce literature about its clinical course and demography. (1) To determine the clinical course and management of CIS. (2) To understand if CIS might be as rare as reported. A 2-month prospective observational study was conducted in the emergency room of a tertiary institution. ENT physicians on call received clinical formation about CIS while emergency physicians did not. During the study period, patients admitted at the emergency room matching the clinical and radiological features of CIS, were included. Information about demographics, iodine exposure, diagnostic workup, clinical course, and management was analyzed. ENT physicians on call detected 4 cases, however, emergency physicians did not. Patients were aged 68–76 years and presented a bilateral submandibular gland swelling debuting 12 to 72 h after an exposure to iodinated contrast. Characteristic ultrasonographic findings supported the diagnosis and the clinical course was self-limited after 60 to 150 h. Physicians’ familiarity with CIS allows its detection and avoids costly and potentially harmful therapeutic/diagnostic efforts. The incidence is probably underestimated; however, further incidence studies are needed.

9 December 2024 in European Annals of Otorhinolaryngology, Head and Neck Diseases
Verified
Journal Article
Closed access
Miguel Saro-BuendíaMiguel Saro-Buendía
Miguel Saro-Buendía
MMMiguel Mansilla-Polo
Miguel Mansilla-Polo
APAlfonso García Piñero
Alfonso García Piñero
MAM. Armengot-Carceller
M. Armengot-Carceller